[HTML][HTML] Pembrolizumab for the treatment of non–small-cell lung cancer
Background We assessed the efficacy and safety of programmed cell death 1 (PD-1)
inhibition with pembrolizumab in patients with advanced non–small-cell lung cancer …
inhibition with pembrolizumab in patients with advanced non–small-cell lung cancer …
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
EB Garon, NA Rizvi, RN Hui, N Leighl… - NEW ENGLAND …, 2015 - scholarworks.bwise.kr
BACKGROUND We assessed the efficacy and safety of programmed cell death 1 (PD-1)
inhibition with pembrolizumab in patients with advanced non-small-cell lung cancer enrolled …
inhibition with pembrolizumab in patients with advanced non-small-cell lung cancer enrolled …
[PDF][PDF] Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
EB Garon, NA Rizvi, R Hui, N Leighl… - N Engl J …, 2015 - scholar.archive.org
Background We assessed the efficacy and safety of programmed cell death 1 (PD-1)
inhibition with pembrolizumab in patients with advanced non–small-cell lung cancer …
inhibition with pembrolizumab in patients with advanced non–small-cell lung cancer …
PEMBROLIZUMAB FOR THE TREATMENT OF NON–SMALL-CELL LUNG CANCER
EB GARON, NA RIZVI, R HUI, N LEIGHL… - NEW ENGLAND …, 2015 - elibrary.ru
BACKGROUND We assessed the efficacy and safety of programmed cell death 1 (PD-1)
inhibition with pembrolizumab in patients with advanced non–small-cell lung cancer …
inhibition with pembrolizumab in patients with advanced non–small-cell lung cancer …
Pembrolizumab for the treatment of non-small-cell lung cancer.
E Garon, N Rizvi, R Hui, N Leighl… - NEW ENGLAND …, 2015 - iris.unicampus.it
BACKGROUND: We assessed the efficacy and safety of programmed cell death 1 (PD-1)
inhibition with pembrolizumab in patients with advanced non-small-cell lung cancer enrolled …
inhibition with pembrolizumab in patients with advanced non-small-cell lung cancer enrolled …
[引用][C] Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
EB Garon, NA Rizvi, R Hui, N Leighl… - New England Journal …, 2015 - cir.nii.ac.jp
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
[HTML][HTML] Pembrolizumab for the treatment of non-small-cell lung cancer
EB Garon, NA Rizvi, R Hui, N Leighl… - NEW ENGLAND …, 2015 - iris.uniroma1.it
BACKGROUND: We assessed the efficacy and safety of programmed cell death 1 (PD-1)
inhibition with pembrolizumab in patients with advanced non-small-cell lung cancer enrolled …
inhibition with pembrolizumab in patients with advanced non-small-cell lung cancer enrolled …
Pembrolizumab for the treatment of non-small-cell lung cancer.
EB Garon, NA Rizvi, R Hui, N Leighl… - The New England …, 2015 - europepmc.org
Background We assessed the efficacy and safety of programmed cell death 1 (PD-1)
inhibition with pembrolizumab in patients with advanced non-small-cell lung cancer enrolled …
inhibition with pembrolizumab in patients with advanced non-small-cell lung cancer enrolled …
Pembrolizumab for the treatment of non-small-cell lung cancer
EB Garon, NA Rizvi, R Hui, N Leighl… - New England Journal …, 2015 - hub.hku.hk
BACKGROUND: We assessed the efficacy and safety of programmed cell death 1 (PD-1)
inhibition with pembrolizumab in patients with advanced non-small-cell lung cancer enrolled …
inhibition with pembrolizumab in patients with advanced non-small-cell lung cancer enrolled …
Pembrolizumab for the treatment of non-small-cell lung cancer
EB Garon, NA Rizvi, R Hui, N Leighl… - The New England …, 2015 - pubmed.ncbi.nlm.nih.gov
Background We assessed the efficacy and safety of programmed cell death 1 (PD-1)
inhibition with pembrolizumab in patients with advanced non-small-cell lung cancer enrolled …
inhibition with pembrolizumab in patients with advanced non-small-cell lung cancer enrolled …